Last reviewed · How we verify

NCT05726201

(POCUS) As an Early Screening Tool for Diagnosing Skull Fractures in Children

Status unknown Last updated 25 July 2023
What this trial tests

trial testing ultrasound in Trauma, Brain in 250 participants. Status unknown.

Timeline
23 July 2023
Primary endpoint
1 October 2025
30 October 2025

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment250
Start date23 July 2023
Primary completion1 October 2025
Estimated completion30 October 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 2 to 18, any sex, with Trauma, Brain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the accuracy of POCUS as a screening tool for early diagnosis of skull fractures in children with mild closed head injuries admitted to the emergency department. The results would aid the emergency physicians to speed up the management and reduce the cost of diagnosing skull fractures and TBI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ultrasound

Trials testing the same drug.

Other recruiting trials for Trauma, Brain

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05726201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing